ATS 2024 Final Program

Click on the session title to view the speakers

300

TUESDAY • MAY 21

CLINICAL • TRANSLATIONAL MINI SYMPOSIUM

BASIC • CLINICAL • TRANSLATIONAL POSTER DISCUSSION SESSION

C100 NEW FRONTIERS IN LUNG CANCER: TOYS, TOOLS AND TREATMENTS 2:15 p.m. - 4:15 p.m. San Diego Convention Center Room 29A-D (Upper Level) Oral Presentations: 2:15 Balancing Potential Benefits and Potential Harms in a Biomarker-informed Risk Assessment for Patients With Pulmonary Nodules 2:27 Performance Comparison of a Blood-based Integrated Classifier for Lung Nodule Risk Stratification in Patients With Versus Without Emphysema 2:39 A Four-protein Blood Biomarker Panel Refines a Clinical Risk Score for Indeterminate Pulmonary Nodules 2:51 Effectiveness and Safety of Transthoracic Shear-wave Ultrasound Elastography in the Diagnosis of Lung Lesions: A Randomized Controlled Trial 3:03 Clinical Evaluation of Standard Convex Probe Endobronchial Ultrasound Versus a Novel Thin Convex Probe Endobronchial Ultrasound Bronchoscopy System 3:15 Navigational Bronchoscopy Versus Computed Tomography-guided Transthoracic Needle Biopsy for the Diagnosis of Indeterminate Lung Nodules: Initial Results From the VERITAS Multicenter Randomized Trial 3:27 A Digital Rose Device for Immediate Feedback on Sample Adequacy and Cancer Presence in Bronchoscopic Biopsies: Initial Results From a Clinical Trial With nsCanary 3:39 A Phase I Dose-escalation Clinical Trial of Bronchoscopic Cryoimmunotherapy 3:51 The First 8 Years — Cardiovascular Immune Related Adverse Events in Checkpoint Inhibitor Recipients With Metastatic Lung Cancer 4:03 Longitudinal Quality of Life Following Sub-lobar Resection and Stereotactic Body Radiation Therapy for Early-stage Non-small Cell Lung Cancer

C101 UNDERSTANDING LUNG IMMUNITY IN THE BATTLE AGAINST INFECTION 2:15 p.m. - 4:15 p.m. San Diego Convention Center Room 25A-C (Upper Level) Poster Viewing 2:15-3:00 Discussion 3:00-4:15 401 Gut Microbiome Contributions to Training Lung Th17 Immunity 402 Sex Differences in Murine Lung Cellular Response to Klebsiella Pneumoniae Infection With Divergent Myeloid Dendritic Cell Gene Ontology 403 Sensory Neuron Release of Vasoactive Intestinal Peptide Regulates Immunoglobulin Release in Response to Streptococcus Pneumoniae Infection 404 Role of Staphylococcus Aureus Superantigens in Cystic Fibrosis Lung Inflammation 406 Selective Phagocytosis by Monocyte-derived Macrophages When Exposed to Single Strains Compared to Communities of Bacteria 407 Immune Cell Infiltration in Aged Mice Is Distinct From Younger Mice Following Chronic Mixed Allergen Exposure 408 Effect of Intra-nasal Administration of Anti-TSLP Antibody in a Murine Model of Dermatophagoides Farinae-induced Allergic Airway Inflammation 409 Macrophage Mechanosensor Transient Receptor Potential Vanilloid 4 (TRPV4) Dampens Bacterial-induced Inflammation Through Negative Regulation of the NF- k B Pathway 410 Outer Membrane Vesicle of Klebsiella Pneumoniae Decrease Bactericidal Properties of Alveolar Macrophages 411 Microphysiological Peripheral and Spinal Nerve Infection by Respiratory Syncytial Virus Drives Activation of Nerve Immunocytes and Peripheral Nerve Hypersensitivity 412 Elicitation of Lung B- and T-Resident Memory Cells (B RM /T RM ) by DNA-Based Gene Therapy Vectors: Impact of aCD20

ATS 2024 Conference Program • San Diego, CA